Table 1

HIV patients description and serologic results

Characteristic
N total (%) (340 patients)
Positive to Bartonella N (%) (76 patients)
Negative to Bartonella N (%) (264 patients)
P-value

Sex



0.611
     Female
82 (24.1)
20 (26.3)
62 (24.4)

     Male
258 (75.9)
56 (73.7)
202 (78.3)

Immunitary state



0.368
     ≤ 200 cell/ml
47 (13.8)
7 (9.2)
40 (15.2)

     > 200 cell/ml
293 (86.2)
69 (90.8)
224 (84.8)

AIDS 1



0.820
     Yes
102 (30)
22 (28.9)
80 (30.3)

     No
238 (70)
54 (71.1)
189 (69.7)

Drugs abuse



0.401
     Yes
196 (57.6)
47 (61.8)
149 (56.4)

     No
144 (42.4)
29 (38.2)
115 (43.6)

Alcohol



0.704
     Yes
97 (28.5)
23 (30.2)
74 (28.0)

     No
243 (71.5)
53 (69.7)
190 (72)

HBV 2,3
17 (5)
3 (3.94)
14 (5.3)
0.449
HCV4
170 (50)
39 (51.3)
37 (48.7)
0.795
Municipality (inhab)



0.667
     >50000
194 (57.0)
45 (59.2)
149 (56.4)

     <50000
146 (43.0)
31 (40.8)
115 (43.6)

Transmission group



0.390
     Heterosexual
62 (18.2)
11 (14.5)
51 (19.3)

     Homosexual
15 (4.4)
1 (1.3)
14 (5.3)

     IDU 5
194 (57.1)
47 (61.8)
147 (55.7)

     Bisexual
5 (1.5)
2 (2.6)
3 (1.1)

     Vertical
3 (0.9)
0 (0)
3 (0.9)

     Unknown
61 (18)
15 (19.7)
46 (17.4)


1: AIDS criteria: Centers for Disease Control and Prevention (CDC) category C; 2: Hepatitis B virus infection; 3: Fisher Exact test; 4: Hepatitis C virus infection ; 5: Injection drug user.

Pons et al. BMC Infectious Diseases 2008 8:58   doi:10.1186/1471-2334-8-58